RAMSAY GENERALE DE SANTE (GDS.PA)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. This filer's financial year end could not be read from its revenue history, so quarters are labelled by the calendar. Amounts in EUR.

Revenue Annual

0 2B 4B 6B 2021: 4B 2022: 4.3B 2023: 4.7B 2024: 5B 2025: 5.2B 2021 2022 2023 2024 2025

Gross Profit Annual

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income Annual

0 100M 200M 300M 2021: 250.6M 2022: 291.3M 2023: 240.4M 2024: 160.6M 2025: 173.2M 2021 2022 2023 2024 2025

Net Income Annual

-50M 0 50M 100M 150M 2021: 73.8M 2022: 127.8M 2023: 63.9M 2024: -36.7M 2025: -38.1M 2021 2022 2023 2024 2025

Cost of Revenue Annual

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow Annual

0 250M 500M 750M 2021: 652.3M 2022: 262.5M 2023: 598.9M 2024: 586.8M 2025: 693.7M 2021 2022 2023 2024 2025

Free Cash Flow Annual

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Shares Outstanding Annual

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

EPS TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.